Cumulative Results from the Call to Action Project (2002 - 2010)

Place holder for Photo

CUMULATIVE RESULTS FROM THE

CALL TO ACTION PROJECT (2002 – 2010)

Nicole Buono, MPHElizabeth Glaser Pediatric AIDS Foundation

Project Background & Context

• EGPAF’s “Call to Action” initiative was launched in 1999 with the help of a Foundation commitment of $1 million, which initially funded 8 sites

• Presidential Initiative preceded PEPFAR, focused on PMTCT

• In Sept 2002, USAID/Washington awarded the Foundation a $100 million grant for a multi-country, service-based program to increase access to and to scale up PMTCT services

2

Project Background & Context

• Since 2002, USAID funds have enabled the implementation of programs in 14 countries as well as operations research studies on topics such as:

– Integrating PMTCT into MCH services

– Improving the use of combination prophylaxis regimens

– Improving postnatal care

• USAID funds also facilitated the identification of, advocacy for changing of key policies related to PMTCT:

– Opt-out testing

– Take-home ARV prophylaxis

– Ipdating the child health card

– HIV counseling and testing in L&D

3

CTA-Supported Countries

4

CTA Expansion

• The number of sites assisted by EGPAF has grown tremendously since the year 2002 with a cumulative total of over 2,600 individual sites having received Foundation support under CTA

• As of December 31, 2009, the CTA project had provided nearly 4 million women with access to PMTCT services

5

Number of PMTCT sites in select CTA countries & the percentage supported by EGPAF (2007)

6

0

100

200

300

400

500

600

700

800

900

1,000

Cameroon Kenya Swaziland Uganda Zimbabwe

EGPAF-Supported PMTCT Sites, 2007 All Other PMTCT Sites, 2007

31%

52%30%

63% 42%

PTMCT Cascade for the CTA Project(2003-2009)

-

500,000

1,000,000

1,500,000

2,000,000

2,500,000

3,000,000

3,500,000

4,000,000

4,500,000

Eligible Counseled Tested Results Tested HIV+

Zimbabwe

Zambia

Uganda

Tanzania

Swaziland

South Africa

Rwanda

Russia

Mozambique

Malawi

Lesotho

Kenya

Cote d`Ivoire

Cameroon

7

PMTCT Cascade for the CTA Project(2003-2009)

-

50,000

100,000

150,000

200,000

250,000

300,000

350,000

400,000

Total HIV+ Women ARV Infant ARV

Zimbabwe

Zambia

Uganda

Tanzania

Swaziland

South Africa

Rwanda

Russia

Mozambique

Malawi

Lesotho

Kenya

Cote d`Ivoire

Cameroon

8

Uptake of Services

By the end of 2009, program data showed:

o 97% of pregnant women were counseled on HIV/AIDS testing

o 92% accepted testing and 99% received HIV test results

o 88% of HIV-positive women received ARV prophylaxis for PMTCT (including those on HAART)

o 61% of HIV-exposed infants received ARV prophylaxis

9

Comparison of PMTCT Cascade Performance: All Africa programs vs. EGPAF CTA programs, 2008

10

0%

20%

40%

60%

80%

100%

Eligible women tested

HIV+ women receiving ARV

Infants receiving ARV

All Africa Programs (2008)

CTA Only (2008)

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

110%

Eligible Women

Women Counseled

Women Tested

Received Results

Tested HIV+

Women Receiving

ARV

Infants Receiving

ARV

Uptake Percentages of PMTCT Services in CTA

Project, 2003-2009

2003

2004

2005

2006

2007

2008

2009

11

Type of PMTCT regimen provided to women in CTA-supported sites (2006-2009)

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

2006 2007 2008 2009

HIV+ women who received ONLY sd-NVP

HIV+ women who received combination prophylaxis or ART

12

DISCLAIMER: This program was made possible through support provided by the Office of HIV/AIDS, Global Bureau Center forPopulation, Health and Nutrition, of the United States Agency for International Development (USAID), through the President’sEmergency Plan for AIDS Relief, as part of the Elizabeth Glaser Pediatric AIDS Foundation's International Family AIDS Initiatives(“Call To Action Project”/ Cooperative Agreement No. GPH-A-00-02-00011-00). Private donors also supported costs of activitiesin many countries. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID.

Thank you!

13